Literatur
- 1
Bardin T, Enel C, Cornelis F, Salski C, Jorgensen C, Ward R, Lathrop G M.
Antibiotic
treatment of venereal disease and Reiter’s syndrome in
a Greenland population.
Arthritis Rheum.
1992
Feb;
35
190-194
- 2
Bas S, Griffais R, Kvien T K, Glennås A, Melby K, Vischer T L.
Amplification
of plasmid and chromosome Chlamydia DNA in synovial fluid of patients
with reactive arthritis and undifferentiated seronegative oligoarthropathies.
Arthritis
Rheum.
1995;
38
1005-1013
- 3
Bas S, Ninet B, Delaspre O, Vischer T L.
Evaluation of
commercially available tests for Chlamydia nucleic acid detection
in synovial fluid of patients.
Br J Rheumatol.
1997;
36
198-202
- 4
Bas S, Vischer T L.
Chlamydia trachomatis
antibody detection and diagnosis of reactive arthritis.
Br
J Rheumatol.
1998;
37
1054-1059
- 5
Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A. et al .
The European
Spondylarthropathy Study Group preliminary criteria for the classification
of spondylarthropathy.
Arthritis Rheum.
1991;
34
218-1227
- 6
Dreses-Werringloer U, Padubrin I, Jurgens-Saathoff B, Hudson A P, Zeidler H, Kohler L.
Persistence of Chlamydia
trachomatis is induced by ciprofloxacin and ofloxacin in vitro.
Antimicrob
Agents Chemother.
2000;
44
3288-3289
- 7
Dreses-Werringloer U, Padubrin I, Zeidler H, Kohler L.
Effects of azithromycin
and rifampicin on Chlamydia trachomatis infection in vitro.
Antimicrob
Agents Chemother.
2001;
45
3001-3008
- 8
El-Gabalawy H S, Goldbach-Mansky R, Smith D 2nd, Arayssi T, Bale S, Gulko P. et al
.
Association
of HLA alleles and clinical features in patients with synovitis
of recent onset.
Arthritis Rheum.
1999;
42
1696-1705
- 9
Fendler C, Leiko S, Sorensen H, Gripenberg-Lerce C, Groh A, Uksila J, Granfors K,
Braun J, Sieper J.
Frequency
of triggering bacteria in patients with reactive arthritis and undifferentiated
oligoarthritis and the relative importance of the tests used for
diagnosis.
Ann Rheum Dis.
2001;
60
377-343
- 10
Granfors K, Viljanen M, Tiilikainen A, Toivanen A.
Persistence of IgM, IgG,
and IgA antibodies to Yersinia in yersinia arthritis.
J
Infect Dis.
1980;
141
424-429
- 11
Hoogkamp-Korstanje J A, Moesker H, Bruyn G A.
Ciprofloxacin v placebo for treatment
of Yersinia enterocolitica triggered reactive arthritis.
Ann
Rheum Dis.
2000;
59
914-917
- 12
Kuipers J G, Nietfeld L, Dreses-Werringloer U, Koehler K, Wollenhaupt J, Zeidler H.
et al .
Optimised
sample preparation of synovial fluid for detection of Chlamydia
trachomatis DNA by polymerase chain reaction.
Ann Rheum
Dis.
1999;
58
103-108
- 13
Kvien T K, Glennås A, Melby K, Granfors K, Andrup O, Karstensen B. et al .
Reactive
arthritis: incidence, triggering agents and clinical presentation.
J
Rheumatol.
1994;
21
115-122
- 14
Lauhio A, Leirisalo-Repo M, Lahdevirta J, Saikku P, Repo H.
Double-blind,
placebo-controlled study of three-month treatment with lymecycline
in reactive arthritis, with special reference to Chlamydia arthritis.
Arthritis
Rheum.
1991;
34
6-14
- 15
Locht H, Kihlstrom E, Lindstrom F D.
Reactive
arthritis after Salmonella among medical doctors-study of an outbreak.
J
Rheumatol.
1993;
20
845-848
- 16
Mattila L, Leirisalo-Repo M, Pelkonen P, Koskimies S, Granfors K, Siitonen A.
Reactive arthritis
following an outbreak of Salmonella Bovismorbificans infection.
J
Infect.
1998;
36
289-295
- 17
Rabenau H, Berger A, Doerr H W, Weber B.
Testing for Chlamydia
trachomatis in urine.
Lancet.
1997;
349
1024-1025
- 18
Sieper J, Braun J, Brandt J, Miksits K, Heesemann J, Laitko S. et al .
Pathogenetic
role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis.
J
Rheumatol.
1992;
19
1236-1242
- 19
Sieper J, Fendler C, Laitko S, Sorensen H, Gripenberg-Lerche C, Hiepe F, Alten R,
Keitel W, Groh A, Uksila J, Eggens U, Granfors K, Braun J.
No benefit
of long-term ciprofloxacin treatment in patients with reactive arthritis
and undifferentiated oligoarthritis: a three-month, multicenter,
double-blind, randomized, placebo-controlled study.
Arthritis Rheum.
1999;
42
1386-1396
- 20
Sieper J, Rudwaleit M, Braun J, van der Heijde D.
Diagnosing reactive arthritis:
role of clinical setting in the value of serologic and microbiologic
assays.
Arthritis Rheum.
2002;
46
319-327
- 21
Toivanen A, Yli-Kerttula T, Luukkainen R, Merilahti-Palo R, Granfors K, Seppala J.
Effect of antimicrobial
treatment on chronic reactive arthritis.
Clin Exp Rheumatol.
1993;
11
301-307
- 22
Wilkens R F.
Reiter’s
syndrome. Evaluation of preliminary criteria for definite disease.
Arthritis
Rheum.
1981;
24
844-849
- 23
Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, Mottonen T, Hakola M, Korpela M, Sanila M,
Parviainen J, Uksila J, Vainionpaa R, Toivanen A.
Effect
of a three month course of ciprofloxacin on the outcome of reactive
arthritis.
Ann Rheum Dis.
2000;
59
565-570
- 24
Zhang Y, Gripenberg-Lerche C, Soderstrom K O, Toivanen A, Toivanen P.
Antibiotic prophylaxis and treatment of
reactive arthritis. Lessons from an animal model.
Arthritis
Rheum.
1996;
39
1238-1243
Korrespondenz
Prof. Dr. med. Joachim Sieper
Universitätsklinikum Benjamin Franklin, Medizinische
Klinik I - Rheumatologie
Hindenburgdamm 30
12200 Berlin
Phone: 030/8445-4547
Fax: 030/8445-4582
Email: hjsieper@zedat.fu-berlin.de
